Patents by Inventor Min Hwan JEONG

Min Hwan JEONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11945276
    Abstract: The present disclosure discloses a preview vehicle height control system and a method of controlling the same. The system includes a monitoring device configured to detect the road surface condition of a driving path of a vehicle, an active suspension configured to adjust a vehicle height, a memory configured to store a plurality of data maps distinguished based on a type of bump, each data map having a vehicle dynamic characteristic as an input and a tuning factor as an output, and a controller configured to derive the tuning factor based on a data map, among the plurality of data maps of the memory, corresponding to the bump detected by the monitoring device, derive a target vehicle height in a form of a Gaussian distribution by substituting the tuning factor, and control the active suspension to follow the derived target vehicle height.
    Type: Grant
    Filed: August 19, 2022
    Date of Patent: April 2, 2024
    Assignees: HYUNDAI MOTOR COMPANY, KIA CORPORATION, FOUNDATION FOR RESEARCH AND BUSINESS SEOUL NATIONAL UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Youngil Sohn, Min Jun Kim, Sang Woo Hwang, Sehyun Chang, Jun Ho Seong, Yong Hwan Jeong, Seong Jin Yim
  • Patent number: 11931431
    Abstract: The present invention relates to a pharmaceutical composition for diagnosing and treating prostate cancer, capable of targeting PSMA, and a compound provided by one aspect of the present invention has a glutamine-urea-lysine compound to which a radioactive metal-coupled chelator is structurally coupled and to which an aryl group that can additionally bind to PSMA protein is coupled. Coupling between the glutamine-urea-lysine compound and the chelator includes a polar spacer so as to serve the role of reducing in vivo nonspecific coupling and exhibit an effect of being rapidly removed from vital organs, but not from prostate cancer. These characteristics lower the radiation exposure, which is caused by a therapeutic radioisotope-coupled compound, to normal tissue and organs, and thus reduce side effects. In addition, a compound that contains a phenyl group having a coupling force with albumin has an increased residence time in the blood, thereby becoming more accumulated in prostate cancer.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: March 19, 2024
    Assignee: FUTURECHEM CO., LTD
    Inventors: Dae Yoon Chi, Byoung Se Lee, So Young Chu, Hyeon Jin Jeong, Min Hwan Kim, Kyo Chul Lee, Yong Jin Lee
  • Publication number: 20230078014
    Abstract: The present invention relates to a method for manufacturing an electrode for a lithium secondary battery, wherein, at the time of manufacturing of an electrode for a lithium secondary battery, a drying speed can be reduced through the steps of: applying a dewatering process using a porous substrate to remove a considerable amount of solvent from electrode slurry in advance; performing pressurization in a state of the porous substrate, an electrode layer, and an electrode current collector; performing additional dewatering; and separating the porous substrate from the electrode layer and then drying the electrode layer, and thus the electrode productivity can be maximized without degradation of electrode performance.
    Type: Application
    Filed: February 18, 2021
    Publication date: March 16, 2023
    Inventors: Kyung Hyun AHN, Hye Jung YOUN, Min Hwan JEONG